Featured News
Phraxis Announces First Commercial Use of EndoForce™
Spartanburg Regional Medical Center successfully completes the first U.S. commercial procedure using the EndoForce™ Anastomotic Connector, performed by Dr. Ari Kramer. This milestone marks the official U.S. launch of EndoForce™ following FDA approval and years of development.
Dr. Alex Yevzlin – VASA Symposium, May 2024
Dr. John Ross – VASA Symposium, May 2024
EndoForce™ Connector for Endovascular Venous Anastomosis: A novel approach for AVG creation
16th April 2024
Burgess JS, Beaver JD, London M et al. Prospective multicenter study of a novel endovascular venous anastomotic procedure and device for implantation of an arteriovenous graft for hemodialysis. J Vasc Access 2023 Mar 9:11297298231159691. doi: 10.1177/11297298231159691. Online ahead of print. PubMed 36895157 Clinical Trial Registration: ClinicalTrials.gov Identifier: NCT02532621
Phraxis presents trial results and extended study data for EndoForce™
18th December 2023